ReviewJournal of dental sciences2025
Oral hairy leukoplakia: The role of Epstein-Barr virus, the occurrence in immunocompetent patients, and the malignant transformation potential.
Review in Journal of dental sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Oral hairy leukoplakia (OHL) was first reported by Greenspan et al., in 1984 and it was observed in a group of male homosexuals in the San Francisco. These lesions are predominantly found on the lateral borders of the tongue and show a corrugated or "hairy" surface. The Epstein-Barr virus (EBV) was then detected in these OHL lesions and proved to be involved in the development of the OHL. Besides, the OHL is also seen in people with immunosuppressive states. In this study, we focused on three different aspects of the OHL: (1) the necessity of presence of the EBV in the OHL lesions; (2) the OHL lesions in immunocompetent patients; (3) the potential of malignant transformation in the OHL lesions. In addition to clinical presentations, histopathological examination of the biopsy specimens with the confirmation of the presence of the EBV in the lesions can make the diagnosis more reliable. Moreover, when the OHL occurs in those who are relatively healthy, a thorough survey to find out the possibly insidious diseases or contributing factors is essential. Furthermore, although the evidence to prove the potential of malignant transformation in the OHL lesions is limited, it still need further investigations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.